gastric cancer tissues; adjacent non-tumor tissues; plasma
-
not specified (other)
Back-Splice Junction PCR / divergent primers PCR; RT-qPCR; Microarray; Clinical Sample Validation; ROC Analysis
May be a novel non-invasive biomarker for gastric cancer diagnosis; AUC was 0.75 in tissues and 0.60 in plasma, and combined tissue and plasma AUC increased to 0.78; expression was correlated with clinicopathological features including tumor diameter, lymphatic metastasis, distal metastasis, TNM stage, and CA19-9.
This study evaluated hsa_circ_0000190 as a clinical biomarker for gastric cancer. hsa_circ_0000190 was down-regulated in gastric cancer tissues and patient plasma, and its expression was associated with several clinicopathological factors and showed diagnostic value by ROC analysis.
0.5662
Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer.
clinical study